Case report of COVID-19 in a Hypertensive patient: Ayurvedic add on therapy
DOI:
https://doi.org/10.47552/ijam.v12i3.1969Keywords:
Ayurveda, AYUSH Kwath, COVID-19, Sanshamani vati, Sudarshan churnAbstract
COVID-19 has affected negatively day to day life and global economy. Considering need for search of immunity modulator drugs for fighting this virus, Ayurvedic treatment was planned. 30 year old female patient, having history of the hypertension was diagnosed as a case of COVID-19 through RT-PCR. AYUSH Kwath (20 ml OD for 7 days), Sanshamani vati(2BD for 7 days), Sudarshan churn (3gm for14 days), Vit –C and Azithromycin given orally for 5 days. RT-PCR sample result was found COVID negative on 7th day of treatment. Antipyretic, anti-inflammatory, immune-modulatory activities were documented earlier of used medications which have shown beneficial result in present case also. Orally administered, add on Ayurvedic formulation exerted symptomatic relief in symptomatic COVID-19 case with pitta-kapha prakriti having co-morbidity of Hypertension. RCT needs to be conducted to validate result in larger sample which will generate evidence for support.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
